I am focusing on Amgen, Inc. (NASDAQ:AMGN) stock because there are two factors that are worthy of excitement. First and foremost, I find the AMGEN stock chart …
Shares of biotech giant Amgen, Inc. (NASDAQ:AMGN), while higher by roughly 19% for the year, also remains a pain trade for momentum-chasing traders as well as …
Shares are trading flat year to date and the stock remains solidly in value territory ... While Array's July-inked deal with Amgen (AMGN) might not have brought in much cash, the agreement to discover and develop drugs for autoimmune …
Institutional investors own 79.12% of the company’s stock. Get Amgen Inc. …
Amgen, Inc. (NASDAQ: AMGN) is up modestly this morning, and for good reason. The company announced positive data from a key clinical trial that was published …
Among the S&P 500’s biggest fallers on Thursday August 10 was Amgen Inc. (AMGN). The stock experienced a 2.56% decline to $169.11 with 3.43 million shares changing hands. Amgen Inc. started at an opening price of 172.07 and hit a …
The stock is now traded at around $21.40. The impact to the portfolio due to this purchase was 0.14%. The holdings …
Amgen Inc. (NASDAQ: AMGN) saw its short interest dropped to 7.81 million shares ... decreased to 3.09 million shares from the previous 3.20 million. The stock
An FDA approval decision could come by mid-April, setting the stage for Rigel to …